DR. JAVIER ACEVEDO M.D.
Prescription History 1356525596
Internal Medicine - Clinical Cardiac Electrophysiology in Orlando, FL

NPI Status: Active since December 24, 2007

Contact Information

1222 S ORANGE AVE
ORLANDO, FL
ZIP 32806
Phone: (321) 841-6444
Fax: (321) 843-4712

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. JAVIER ACEVEDO M.D., an active Clinical Cardiac Electrophysiology specialist practicing in Orlando, FL. Our medical registry currently tracks 15 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 1,051 documented patient claims. Among these therapy options, the most frequently utilized medication is Eliquis, which accounts for 260 claims alone.


Amiodarone Hcl

Generic Formulation: Amiodarone HclSpecialty: Clinical Cardiac Electrophysiology
Provider Metrics Summary
Total Claims 184
30-Day Fills 394.0
Days Supply 11,595
FL State Average Benchmarks
Peer Average Claims33.0
Peer Average 30-Day Fills70.3
Peer Average Days Supply2,069
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 457.6% higher than the standard regional baseline profile for FL. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,099.21 across this reporting matrix range.

Provider Avg Cost Per Claim

$11.41

State Avg Cost Per Claim

$33.56

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat certain types of serious (possibly fatal) irregular heartbeat (such as recurrent ventricular fibrillation/tachycardia). It is used to restore normal heart rhythm and maintain a regular, steady heartbeat. Amiodarone is known as an anti-arrhythmic drug. It works by blocking certain electrical signals in the heart that can cause an irregular heartbeat.

Clopidogrel

Generic Formulation: Clopidogrel BisulfateSpecialty: Clinical Cardiac Electrophysiology
Provider Metrics Summary
Total Claims 16
30-Day Fills 22.0
Days Supply 648
FL State Average Benchmarks
Peer Average Claims64.0
Peer Average 30-Day Fills155.5
Peer Average Days Supply4,631
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 75.0% less volume than the regional standard for practitioners inside FL. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $260.54 across this reporting matrix range.

Provider Avg Cost Per Claim

$16.28

State Avg Cost Per Claim

$15.02

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A ticlopidine analog and platelet purinergic P2Y receptor antagonist that inhibits adenosine diphosphate-mediated PLATELET AGGREGATION. It is used to prevent THROMBOEMBOLISM in patients with ARTERIAL OCCLUSIVE DISEASES; MYOCARDIAL INFARCTION; STROKE; or ATRIAL FIBRILLATION.

Therapeutic Applications

Clopidogrel is used to prevent heart attacks and strokes in persons with heart disease (recent heart attack), recent stroke, or blood circulation disease (peripheral vascular disease). It is also used with aspirin to treat new/worsening chest pain (new heart attack, unstable angina) and to keep blood vessels open and prevent blood clots after certain procedures (such as cardiac stent). Clopidogrel works by blocking platelets from sticking together and prevents them from forming harmful clots. It is an antiplatelet drug. It helps keep blood flowing smoothly in your body.

Diltiazem Hcl

Generic Formulation: Diltiazem HclSpecialty: Clinical Cardiac Electrophysiology
Provider Metrics Summary
Total Claims 16
30-Day Fills 28.7
Days Supply 860
FL State Average Benchmarks
Peer Average Claims23.0
Peer Average 30-Day Fills44.7
Peer Average Days Supply1,295
Conservative Utilization

This provider writes prescriptions for this formulation 30.4% less frequently than the standard regional baseline metric for practitioners inside FL. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $617.41 across this reporting matrix range.

Provider Avg Cost Per Claim

$38.59

State Avg Cost Per Claim

$36.54

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Diltiazem is used to prevent chest pain (angina). It may help to increase your ability to exercise and decrease how often you may get angina attacks. Diltiazem is called a calcium channel blocker. It works by relaxing blood vessels in the body and heart and lowers the heart rate. Blood can flow more easily and your heart works less hard to pump blood.

Dofetilide

Generic Formulation: DofetilideSpecialty: Clinical Cardiac Electrophysiology
Provider Metrics Summary
Total Claims 44
30-Day Fills 69.3
Days Supply 2,064
FL State Average Benchmarks
Peer Average Claims37.0
Peer Average 30-Day Fills77.1
Peer Average Days Supply2,297
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across FL. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $3,959.26 across this reporting matrix range.

Provider Avg Cost Per Claim

$89.98

State Avg Cost Per Claim

$302.66

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat certain types of serious (possibly fatal) irregular heartbeat (such as atrial fibrillation/flutter). It is used to restore normal heart rhythm and maintain a regular, steady heartbeat. Dofetilide is known as an anti-arrhythmic drug. It works by blocking the activity of certain electrical signals in the heart that can cause an irregular heartbeat. Treating an irregular heartbeat can decrease the risk for blood clots, and this effect can reduce your risk of heart attack or stroke.

Eliquis

Generic Formulation: ApixabanSpecialty: Clinical Cardiac Electrophysiology
Provider Metrics Summary
Total Claims 260
30-Day Fills 467.0
Days Supply 13,961
FL State Average Benchmarks
Peer Average Claims79.0
Peer Average 30-Day Fills130.4
Peer Average Days Supply3,717
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 229.1% higher than the standard regional baseline profile for FL. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $270,386.04 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,039.95

State Avg Cost Per Claim

$852.21

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Apixaban is used to prevent serious blood clots from forming due to a certain irregular heartbeat (atrial fibrillation) or after hip/knee replacement surgery. With atrial fibrillation, part of the heart does not beat the way it should. This can lead to blood clots forming, which can travel to other parts of your body (such as the lungs or legs) or increase your risk for stroke. In the United States, apixaban is also approved to treat certain types of blood clots (deep vein thrombosis-DVT, pulmonary embolus-PE) and to prevent them from forming again. Apixaban is an anticoagulant that works by blocking certain clotting proteins in your blood.

Enalapril Maleate

Generic Formulation: Enalapril MaleateSpecialty: Clinical Cardiac Electrophysiology
Provider Metrics Summary
Total Claims 18
30-Day Fills 44.5
Days Supply 1,311
FL State Average Benchmarks
Peer Average Claims27.0
Peer Average 30-Day Fills68.9
Peer Average Days Supply2,058
Conservative Utilization

This provider writes prescriptions for this formulation 33.3% less frequently than the standard regional baseline metric for practitioners inside FL. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $376.21 across this reporting matrix range.

Provider Avg Cost Per Claim

$20.90

State Avg Cost Per Claim

$24.68

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An angiotensin-converting enzyme inhibitor that is used to treat HYPERTENSION and HEART FAILURE.

Therapeutic Applications

Enalapril is used to treat high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. It is also used to treat heart failure and to help prevent people with a certain heart problem (left ventricular dysfunction) from developing heart failure. Enalapril belongs to a class of drugs known as ACE inhibitors. It works by relaxing blood vessels so blood can flow more easily.

Entresto

Generic Formulation: Sacubitril/ValsartanSpecialty: Clinical Cardiac Electrophysiology
Provider Metrics Summary
Total Claims 14
30-Day Fills 23.0
Days Supply 660
FL State Average Benchmarks
Peer Average Claims46.0
Peer Average 30-Day Fills75.7
Peer Average Days Supply2,215
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 69.6% less volume than the regional standard for practitioners inside FL. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $11,866.16 across this reporting matrix range.

Provider Avg Cost Per Claim

$847.58

State Avg Cost Per Claim

$1,017.05

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This product is used to treat certain types of heart failure. It may help you live longer and lower your chance of having to go to the hospital for heart failure. This product contains 2 medications: sacubitril and valsartan. Sacubitril belongs to a class of drugs called neprilysin inhibitors and valsartan belongs to a class of drugs called angiotensin receptor blockers (ARBs). They work by relaxing blood vessels so that blood can flow more easily, which makes it easier for your heart to pump blood to your body.

Flecainide Acetate

Generic Formulation: Flecainide AcetateSpecialty: Clinical Cardiac Electrophysiology
Provider Metrics Summary
Total Claims 64
30-Day Fills 157.0
Days Supply 4,710
FL State Average Benchmarks
Peer Average Claims39.0
Peer Average 30-Day Fills94.1
Peer Average Days Supply2,803
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 64.1% higher than the standard regional baseline profile for FL. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $3,007.90 across this reporting matrix range.

Provider Avg Cost Per Claim

$47.00

State Avg Cost Per Claim

$76.13

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A potent anti-arrhythmia agent, effective in a wide range of ventricular and atrial ARRHYTHMIAS and TACHYCARDIAS.

Therapeutic Applications

This medication is used to treat certain types of serious (possibly fatal) irregular heartbeat (such as sustained ventricular tachycardia and paroxysmal supraventricular tachycardia). It is used to restore normal heart rhythm and maintain a regular, steady heartbeat. It is also used to prevent certain types of irregular heartbeat from returning (such as atrial fibrillation). Flecainide is known as an anti-arrhythmic drug. It works by blocking certain electrical signals in the heart that can cause an irregular heartbeat. Treating an irregular heartbeat can decrease the risk for blood clots, and this effect can reduce your risk of heart attack or stroke. Older adults should discuss the risks and benefits of this medication with their doctor or pharmacist, as well as other effective and possibly safer treatments.

Hydralazine Hcl

Generic Formulation: Hydralazine HclSpecialty: Clinical Cardiac Electrophysiology
Provider Metrics Summary
Total Claims 21
30-Day Fills 47.0
Days Supply 1,410
FL State Average Benchmarks
Peer Average Claims39.0
Peer Average 30-Day Fills83.4
Peer Average Days Supply2,462
Conservative Utilization

This provider writes prescriptions for this formulation 46.2% less frequently than the standard regional baseline metric for practitioners inside FL. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $442.93 across this reporting matrix range.

Provider Avg Cost Per Claim

$21.09

State Avg Cost Per Claim

$21.06

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Hydralazine is used with or without other medications to treat high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Hydralazine is called a vasodilator. It works by relaxing blood vessels so blood can flow through the body more easily.

Metoprolol Succinate

Generic Formulation: Metoprolol SuccinateSpecialty: Clinical Cardiac Electrophysiology
Provider Metrics Summary
Total Claims 137
30-Day Fills 336.3
Days Supply 10,075
FL State Average Benchmarks
Peer Average Claims99.0
Peer Average 30-Day Fills252.4
Peer Average Days Supply7,535
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 38.4% more claims than the standard regional baseline profile for FL. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $3,263.53 across this reporting matrix range.

Provider Avg Cost Per Claim

$23.82

State Avg Cost Per Claim

$20.16

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.

Therapeutic Applications

This medication is a beta-blocker used to treat chest pain (angina), heart failure, and high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. This drug works by blocking the action of certain natural chemicals in your body (such as epinephrine) that affect the heart and blood vessels. This lowers heart rate, blood pressure, and strain on the heart.

Metoprolol Tartrate

Generic Formulation: Metoprolol TartrateSpecialty: Clinical Cardiac Electrophysiology
Provider Metrics Summary
Total Claims 34
30-Day Fills 80.0
Days Supply 2,400
FL State Average Benchmarks
Peer Average Claims78.0
Peer Average 30-Day Fills185.6
Peer Average Days Supply5,510
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 56.4% less volume than the regional standard for practitioners inside FL. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $199.99 across this reporting matrix range.

Provider Avg Cost Per Claim

$5.88

State Avg Cost Per Claim

$7.36

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.

Therapeutic Applications

Metoprolol is used with or without other medications to treat high blood pressure (hypertension). Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. This medication is also used to treat chest pain (angina) and to improve survival after a heart attack. Metoprolol belongs to a class of drugs known as beta blockers. It works by blocking the action of certain natural chemicals in your body, such as epinephrine, on the heart and blood vessels. This effect lowers the heart rate, blood pressure, and strain on the heart.

Pantoprazole Sodium

Generic Formulation: Pantoprazole SodiumSpecialty: Clinical Cardiac Electrophysiology
Provider Metrics Summary
Total Claims 45
30-Day Fills 130.0
Days Supply 3,900
FL State Average Benchmarks
Peer Average Claims80.0
Peer Average 30-Day Fills182.3
Peer Average Days Supply5,421
Conservative Utilization

This provider writes prescriptions for this formulation 43.8% less frequently than the standard regional baseline metric for practitioners inside FL. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $502.13 across this reporting matrix range.

Provider Avg Cost Per Claim

$11.16

State Avg Cost Per Claim

$16.03

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.

Therapeutic Applications

Pantoprazole is used to treat certain stomach and esophagus problems (such as acid reflux). It works by decreasing the amount of acid your stomach makes. This medication relieves symptoms such as heartburn, difficulty swallowing, and cough. It helps heal acid damage to the stomach and esophagus, helps prevent ulcers, and may help prevent cancer of the esophagus. Pantoprazole belongs to a class of drugs known as proton pump inhibitors (PPIs).

Sotalol

Generic Formulation: Sotalol HclSpecialty: Clinical Cardiac Electrophysiology
Provider Metrics Summary
Total Claims 112
30-Day Fills 233.5
Days Supply 6,960
FL State Average Benchmarks
Peer Average Claims33.0
Peer Average 30-Day Fills82.5
Peer Average Days Supply2,461
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 239.4% higher than the standard regional baseline profile for FL. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,147.90 across this reporting matrix range.

Provider Avg Cost Per Claim

$10.25

State Avg Cost Per Claim

$28.16

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat a serious (possibly life-threatening) type of fast heartbeat called sustained ventricular tachycardia. It is also used to treat certain fast/irregular heartbeats (atrial fibrillation/flutter) in patients with severe symptoms such as weakness and shortness of breath. Sotalol helps to lessen these symptoms. It slows the heart rate and helps the heart to beat more normally and regularly. This medication is both a beta blocker and an anti-arrhythmic.

Sucralfate

Generic Formulation: SucralfateSpecialty: Clinical Cardiac Electrophysiology
Provider Metrics Summary
Total Claims 56
30-Day Fills 56.0
Days Supply 777
FL State Average Benchmarks
Peer Average Claims30.0
Peer Average 30-Day Fills43.5
Peer Average Days Supply1,205
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 86.7% higher than the standard regional baseline profile for FL. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,211.22 across this reporting matrix range.

Provider Avg Cost Per Claim

$21.63

State Avg Cost Per Claim

$59.21

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A basic aluminum complex of sulfated sucrose.

Therapeutic Applications

This medication is used to treat ulcers in the intestines. Sucralfate forms a coating over ulcers, protecting the area from further injury. This helps ulcers heal more quickly.

Xarelto

Generic Formulation: RivaroxabanSpecialty: Clinical Cardiac Electrophysiology
Provider Metrics Summary
Total Claims 30
30-Day Fills 66.0
Days Supply 1,960
FL State Average Benchmarks
Peer Average Claims46.0
Peer Average 30-Day Fills82.4
Peer Average Days Supply2,380
Conservative Utilization

This provider writes prescriptions for this formulation 34.8% less frequently than the standard regional baseline metric for practitioners inside FL. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $36,234.56 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,207.82

State Avg Cost Per Claim

$917.55

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A morpholine and thiophene derivative that functions as a FACTOR XA INHIBITOR and is used in the treatment and prevention of DEEP-VEIN THROMBOSIS and PULMONARY EMBOLISM. It is also used for the prevention of STROKE and systemic embolization in patients with non-valvular ATRIAL FIBRILLATION, and for the prevention of atherothrombotic events in patients after an ACUTE CORONARY SYNDROME.

Therapeutic Applications

Rivaroxaban is used to prevent blood clots from forming due to a certain irregular heartbeat (atrial fibrillation) or after hip or knee replacement surgery. It is also used to prevent blood clots from forming in high-risk patients with limited mobility during their hospital stay and after discharge. In addition, rivaroxaban is used to treat blood clots (such as in deep vein thrombosis-DVT or pulmonary embolus-PE) and to prevent the blood clots from forming again. Rivaroxaban may be used in children to prevent blood clots from forming after a certain heart surgery (Fontan procedure). Rivaroxaban is an anticoagulant that works by blocking certain clotting proteins in your blood.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like DR. JAVIER ACEVEDO M.D. provides transparency into local medical care patterns within Orlando, FL.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Clinical Cardiac Electrophysiology** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.